Medication info
Mega Atova Tablet 20mg (Atorvastatin Calcium Hydrate)

Mega Atova Tablet 20mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.69mg / 1 tablet
Manufacturer / importer
L&C Bio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201902753 · Approved 2019.04.29 · Insurance code 060500760

Summary

Main use
Improvement of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients taking atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
Children's dosage
Aged 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
L&C Bio Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • vascular procedures
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication reduces the risk of myocardial infarction and stroke in adults with cardiovascular disease risk factors and in patients with type 2 diabetes. It also lowers the need for vascular procedures and the risk of hospitalization due to angina and congestive heart failure. In patients with hyperlipidemia, it helps decrease total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels, while increasing good HDL cholesterol to improve blood lipids. It is particularly effective in children and adolescents with familial hypercholesterolemia and is recommended for patients at high risk of early cardiovascular diseases. This drug is used to protect heart health and improve blood lipid levels.

Dosage and Administration

Adult dosage

Patients taking atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.

Children's dosage

Aged 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may pose a risk of muscle problems; thus, if muscle pain or weakness worsens or if creatine kinase levels rise significantly, stop taking the medication immediately and consult a physician. Individuals with poor liver function or liver disease should not take this medication, and if symptoms of liver dysfunction occur during treatment, they should inform a doctor immediately. Women who are pregnant, may become pregnant, or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraceptive methods while taking it. Children under 10 years of age and patients with muscle disorders should also avoid this medication. Patients with a history of alcohol addiction or liver disease should use this medication cautiously, and elderly patients aged 70 or older are at higher risk of muscle-related side effects and should be monitored closely. This medication can interact with other drugs, so it is essential to inform your physician or pharmacist, especially if you are taking certain antibiotics, antifungals, protease inhibitors, or some cardiovascular drugs. Be cautious if taking this medication with grapefruit juice or certain other drugs, as it may increase the blood concentration of the medication and heighten the risk of side effects. If symptoms such as muscle pain, weakness, fever, or fatigue develop while taking this medication, notify a doctor immediately and get tested, and discontinue use if necessary. Regular monitoring of liver function tests and blood creatine kinase levels is necessary, and immediate action should be taken if abnormalities are found. Store this medication out of reach of children, and keep it in its original container. There is no specific antidote for overdose; treatment should be symptom-based, while closely monitoring liver function and muscle condition.

Side effects

  • Weakness
  • malaise
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 163 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vasomotor edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gum bleeding
  • acute intestinal obstruction
  • bronchitis
  • rhinitis
  • pneumonia
  • shortness of breath
  • asthma
  • sensory abnormalities
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • anxiety
  • myositis
  • muscular disorders
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypothermia
  • increased non-protein nitrogen
  • hyperlipidemia
  • facial flushing
  • sleep disturbances
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • cognitive impairment
  • severe muscle weakness
  • oculobulbar weakness
  • increased AST
  • fulminant hepatitis
  • jaundice
  • muscle pain
  • muscle weakness
  • myoglobinuria
  • acute renal failure
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best kept at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.